TEVA AJOVY

In fall 2019, Teva wanted to shake up its branding while continuing to emphasize the ease of access to Ajovy, its migraine treatment. Ajovy’s target demographic is mainly middle-aged and senior women.

Our digital ads captured three aspects of Ajovy:

1. Dosing options: Patients can either receive one shot every three months or smaller doses monthly.

2. Accessibility: Ajovy is Medicare eligible

3. Balance: Using Ajovy will free them to maintain their lifestyle while receiving migraine treatment.